AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-pharmaceutical company dedicated to the development of novel drugs and diagnostics for humans and animals, has been invited to present at the 21st Annual ROTH Capital Partners OC Growth Stock Conference. The conference will be held February 16-18, 2009 at the Ritz-Carlton, Laguna Niguel in Dana Point, California.
ROTH Capital Partners Stock Conferences are among the largest in the nation for micro and small-cap companies in technology, healthcare, financial services and consumer products sectors. More than 1,000 institutional investors are expected to attend.
The company's recently appointed executive chairman, Daryl J. Faulkner, is scheduled to present on Wednesday, February 18 at 3:30 p.m. Pacific time (6:30 p.m. Eastern time), followed by a break out session and one-on-one meetings. Faulkner will discuss AppyScore(TM), the company's blood-based human diagnostic tests designed as an aid in the diagnosis of human appendicitis. The presentation will be available via webcast at http://www.wsw.com/webcast/roth20/appy.
As the company's new executive chairman, Faulkner brings to AspenBio more than 25 years' experience in developing and commercializing medical devices, drug and drug delivery systems, life science research tools, and molecular diagnostics.
For more information, please visit the conference website at www.rothconference.com or call a ROTH representative at 800-933-6830.